Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00243711 · ClinicalTrials.gov registry record · Phase 2
A Multi-Center Randomized Study to Evaluate the Efficacy and Safety of an Investigational Lubricant Eye Drop
A Phase 2 study, sponsored by Allergan.
- Completed
- Registry status
- Phase 2
- Development phase
- 286
- Enrollment target
NCT00243711 is a Phase 2 study that has completed, run by Allergan. The registered enrollment target is 286 participants.
The verdict
NCT00243711, a Phase 2 study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 286 participants
- Enrollment target
Study Summary
The efficacy, safety and acceptability of an investigational lubricant eye drop in subjects with dry eye will be evaluated in comparison with currently-available lubricant eye drops.
Interventions
- DRUG Carboxymethylcellulose sodium and Glycerin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 286 participants |
| Start Date | 2005-09 |
| Est. Completion | 2006-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00243711
The ClinicalTrials.gov registry entry for NCT00243711 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 286 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Carboxymethylcellulose sodium and Glycerin is the first listed.
NCT00243711 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00243711 about?
NCT00243711 is a clinical study titled "A Multi-Center Randomized Study to Evaluate the Efficacy and Safety of an Investigational Lubricant Eye Drop". The efficacy, safety and acceptability of an investigational lubricant eye drop in subjects with dry eye will be evaluated in comparison with currently-available lubricant eye drops.
What is the current status of trial NCT00243711?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 286 participants. The study started on 2005-09. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00243711?
The interventions under investigation include: Carboxymethylcellulose sodium and Glycerin (DRUG).
Who is sponsoring clinical trial NCT00243711?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.